Clinical Trials Logo

Clinical Trial Details — Status: Recruiting

Administrative data

NCT number NCT04934462
Other study ID # Hip Microinstability Study
Secondary ID
Status Recruiting
Phase N/A
First received
Last updated
Start date November 26, 2021
Est. completion date January 2025

Study information

Verified date March 2022
Source Göteborg University
Contact Axel Öhlin, MD, PhD
Phone 00460313430752
Email axel.ohlin@gmail.com
Is FDA regulated No
Health authority
Study type Interventional

Clinical Trial Summary

Microinstability of the hip joint is an important cause of hip pain and reduced hip function in young and active individuals. Hip microinstability is due to extraphysiologic hip motion and could be secondary to acetabular dysplasia, connective tissue disorder, macrotrauma, microtrauma, iatrogenic- and idiopathic causes. Treatment for hip microinstability is initiated with non-surgical treatment consisting of physiotherapy aimed mainly at stability. If non-surgical treatment fails, surgery with arthroscopic plication of the hip joint capsule is the preferred method. This study evaluates non-surgical and arthroscopic treatment for hip microinstability regarding hip function and adverse events.


Description:

This is a prospective cohort study evaluating 26 participants above 18 years of age undergoing non-surgical and surgical treatment for microinstability of the hip joint. Participants with findings on physical examination and imaging suggestive of hip microinstability will undergo six months of physiotherapy aimed at stabilizing the hip joint. If non-surgical treatment fails, a diagnostic hip arthroscopy will be performed, and if hip microinstability is confirmed, the participants will undergo a plication of the hip joint capsule. Participants will be evaluated with Patient-Reported Outcome Scores (PROMs) and strength- and function tests at time of enrollment and at 6-, 12- and 24 months following treatment. The primary outcome is hip function determined by PROMs and strength- and function tests. Secondary outcomes include Health-Related Quality of Life (HRQL), sport activity level and adverse events.


Recruitment information / eligibility

Status Recruiting
Enrollment 26
Est. completion date January 2025
Est. primary completion date January 2025
Accepts healthy volunteers No
Gender All
Age group 18 Years and older
Eligibility Inclusion Criteria: - Hip microinstability - Minimum 18 years old Exclusion Criteria: - Hip osteoarthritis - Severe hip dysplasia - Perthes disease or avascular necrosis of the femoral head - Previous surgery to the hip joint

Study Design


Related Conditions & MeSH terms


Intervention

Procedure:
physiotherapy
Six months physiotherapy aimed at hip stability.
arthroscopy
Arthroscopic plication of hip joint capsule.

Locations

Country Name City State
Sweden GHP Ortho Center Göteborg Gothenburg
Sweden University of Gothenburg Gothenburg
Sweden Capio Artro Clinic Stockholm

Sponsors (3)

Lead Sponsor Collaborator
Göteborg University Stanford University, The Gothenburg Society of Medicine

Country where clinical trial is conducted

Sweden, 

Outcome

Type Measure Description Time frame Safety issue
Primary Mean Change from Baseline in Hip Function on the International Hip Outcome Tool (iHOT-12) at 24 Months Participant-reported hip function. Minimum score 0, maximum score 100 (higher score mean a better outcome). 24 Months
Primary Mean Change from Baseline in Hip Function on the Copenhagen Hip and Groin Outcome Score (HAGOS) at 24 Months Participant-reported hip function. Minimum score 0, maximum score 100 (higher score mean a better outcome). 24 Months
Primary Mean Change from Baseline in Maximal Isometric Hip Muscle Force in Newton at 24 Months Maximal hip isometric muscle force will be assessed using a dynamometer (Hoggan MicroFET2, Hoggan, Scientific L.L.C., Salt Lake City, USA) for hip flexion, adduction, abduction, and extension. The maximal developed force in Newton will be recorded. Higher Newton value means a better outcome. 24 Months
Primary Mean Change from Baseline in Hop Performance at 24 Months Hop performance will be measured with 3 single-leg hops: vertical hop (Muscle lab, Ergotest Technology, Oslo, Norway), hop for distance and a 30-second side-hop test. Each hop test is performed with the patients holding their hands behind their back. For the vertical hop, the time from take-off to landing is converted into hop height in centimeters. In the hop for distance test, the distance between top of the toes at take-off to heel at landing is measured in centimeters. For the 30 second side hop test, one trial per leg is allowed, where the patient is instructed to hop as many times as possible over 2 lines 40 centimeters apart. The number of hops is recorded. Higher height, longer distance and higher number of hops means a better outcome. 24 Months
Secondary Mean Change from Baseline in Hip Function on the EuroQoL-5 Dimensions (EQ-5D) at 24 Months Participant-reported health-related quality of life. Minimum score 0, maximum score 1 (higher score mean a higher health-related quality of life). 24 Months
Secondary Mean Change from Baseline in Hip Function on the Hip Sport Activity Scale (HSAS) at 24 Months Participant-reported sport activity level. Minimum score 0, maximum score 8 (higher score mean a higher sport activity level). 24 Months
Secondary Type and Number of Adverse Events at 24 Months Adverse events collected via phone interview. 24 Months
Secondary Single Question "Satisfied with Treatment?" at 24 Months Participant-reported satisfaction with treatment (yes/no). 24 Months
See also
  Status Clinical Trial Phase
Withdrawn NCT04720274 - Utilizing EMG Shorts in Hip Population N/A
Not yet recruiting NCT05484778 - Analysis of Balance and Functional Hop Tests Used for Return to Sports in Athletes With Lower Extremity Injuries by Dual Task Study N/A
Withdrawn NCT05030688 - Fascia Iliaca Compartment Block and PENG Block for Hip Arthroplasty N/A
Completed NCT04070430 - Crutch Use After Arthroscopic Hip Surgery N/A
Completed NCT03172923 - Nail Versus Sliding Hip Screw for Trochanteric Hip Fractures N/A
Active, not recruiting NCT04925791 - Does Limb Pre-Conditioning Reduce Pain After Hip Arthroscopy N/A
Completed NCT06087549 - PENG Block vs. ESP Block for Pediatric Hip Surgery Phase 4
Recruiting NCT05038709 - Positioning for Hip Arthroscopic Surgery to Reduce Postoperative Numbness N/A
Recruiting NCT05397145 - Iliopsoas Plane Block vs PENG Block for Hip Arthroplasty N/A
Recruiting NCT06212622 - Is the Rate of Early Mobilisation in Hip Fracture Patients Using Alfentanil Better Than Standard Opioid Analgesia?
Not yet recruiting NCT05762588 - JuggerKnot With Broadband PMCF Study
Completed NCT05245097 - Mitigation of Major Hip Injury Due to Fall With a Smart Belt N/A
Recruiting NCT06064136 - Psoas Tenotomy Under Ultrasound N/A
Completed NCT02990234 - Capsular Repair in FAI Impingement Surgery N/A
Completed NCT02630160 - The Influence of Local Infiltration Analgesia by Catheter in Postoperative Control Pain After Total Hip Replacement Phase 4
Recruiting NCT06332443 - Randomized, Controlled Trial Comparing the Effectiveness of Sedation-Epidural Anesthesia to Spinal Anesthesia in Outpatient Hip or Knee Arthroplasty. N/A
Completed NCT05343195 - Balance and Leg Function After Hip Replacement N/A
Completed NCT04210440 - The Treatment of Initial Stage of Hip Osteonecrosis: the Core Decompression N/A
Completed NCT01833481 - THA Kinematics and Sound for Subjects Implanted Using Various Surgical Approaches
Completed NCT03959254 - Specific Protocoled Physiotherapy Treatment for Subjects Surgically Treated for Femoroacetabular Syndrome N/A